Higher Risk Myelodysplastic Syndrome (MDS)

Also known as: Higher-risk Myelodysplastic Syndromes / Higher risk myelodysplastic syndromes / Higher Risk Myelodysplastic Syndrome / Higher-Risk Myelodysplastic Syndrome (HR-MDS) / Higher Risk Myelodysplastic Syndrome (HR-MDS) / Higher-risk Myelodysplastic Syndrome

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00928Azacitidine1Completed1
DB17247Bisantrene1Withdrawn1
DB15694Cedazuridine1Withdrawn1
DB00987Cytarabine1Withdrawn1
DB01262Decitabine1Withdrawn1
DB17271Galinpepimut-S1Active Not Recruiting1
DB17166Tapotoclax1Completed1
DB00928Azacitidine1 / 2Active Not Recruiting1
DB00928Azacitidine1 / 2Recruiting1
DB01234Dexamethasone1 / 2Active Not Recruiting1
DB01234Dexamethasone1 / 2Recruiting1
DB16153Eltanexor1 / 2Active Not Recruiting1
DB17573Evorpacept1 / 2Active Not Recruiting1
DB17514Inobrodib1 / 2Recruiting1
DB08910Pomalidomide1 / 2Recruiting1
DB11581Venetoclax1 / 2Recruiting1
DB00928Azacitidine2Recruiting1
DB00531Cyclophosphamide2Completed1
DB17542Ligufalimab2Recruiting1
DB09035Nivolumab2Completed1
DB01262Decitabine4Unknown Status1